Background: Controversy over blood pressure (BP) treatment targets for individuals with diabetes is in part due to conflicting perspectives about generalizability of available trial data. Objective: The authors sought to estimate how results from the largest clinical trial of intensive BP treatment among adults with diabetes would generalize to the U.S. population. Methods: The authors used transportability methods to reweight individual patient data from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial (N = 4,507) of intensive (goal systolic BP <120 mm Hg) versus standard (goal systolic BP <140 mm Hg) treatment to better represent the demographic and clinical risk factors of the U.S. population of adults with diabete...
The Systolic Blood Pressure Intervention Trial (SPRINT) enrolled 9361 participants aged ≥50 years in...
BackgroundEarly hypertension control reduces the risk of cardiovascular complications among patients...
BACKGROUND: SPRINT (Systolic Blood Pressure Intervention Trial) and the ACCORD (Action to Control Ca...
Aim: We looked to decide if the pulse levels at which cardiovascular insurance is accomplished vary ...
Background: Clinical guidelines vary in determining optimal blood pressure targets in adults with di...
Background: Recent guidelines recommended a systolic blood pressure (SBP) target of < 130 mmHg for p...
Systolic blood pressure (SBP) treatment targets for adults with diabetes mellitus remain unclear. SB...
OBJECTIVE To determine the concordance in the prevalence of hypertension and pharmacological antihyp...
Objective: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes...
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We ex...
BACKGROUND: Controversy exists as to whether the threshold for blood pressure-lowering treatment sho...
BACKGROUND—There is no evidence from randomized trials to support a strategy of lowering systolic bl...
IntroductionBlood pressure measurement in clinical care settings seldom follows the protocol recomme...
OBJECTIVE Despite widespread dissemination of target values, achieving a blood pressure of <130/80 m...
OBJECTIVE:: Multiple systematic reviews address the effect of antihypertensive treatment in people w...
The Systolic Blood Pressure Intervention Trial (SPRINT) enrolled 9361 participants aged ≥50 years in...
BackgroundEarly hypertension control reduces the risk of cardiovascular complications among patients...
BACKGROUND: SPRINT (Systolic Blood Pressure Intervention Trial) and the ACCORD (Action to Control Ca...
Aim: We looked to decide if the pulse levels at which cardiovascular insurance is accomplished vary ...
Background: Clinical guidelines vary in determining optimal blood pressure targets in adults with di...
Background: Recent guidelines recommended a systolic blood pressure (SBP) target of < 130 mmHg for p...
Systolic blood pressure (SBP) treatment targets for adults with diabetes mellitus remain unclear. SB...
OBJECTIVE To determine the concordance in the prevalence of hypertension and pharmacological antihyp...
Objective: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes...
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We ex...
BACKGROUND: Controversy exists as to whether the threshold for blood pressure-lowering treatment sho...
BACKGROUND—There is no evidence from randomized trials to support a strategy of lowering systolic bl...
IntroductionBlood pressure measurement in clinical care settings seldom follows the protocol recomme...
OBJECTIVE Despite widespread dissemination of target values, achieving a blood pressure of <130/80 m...
OBJECTIVE:: Multiple systematic reviews address the effect of antihypertensive treatment in people w...
The Systolic Blood Pressure Intervention Trial (SPRINT) enrolled 9361 participants aged ≥50 years in...
BackgroundEarly hypertension control reduces the risk of cardiovascular complications among patients...
BACKGROUND: SPRINT (Systolic Blood Pressure Intervention Trial) and the ACCORD (Action to Control Ca...